(Q48221695)

9 February 2018

title

Yohimbine premedication and 35% CO2 vulnerability in healthy volunteers (English)

1 reference

9 February 2018

author name string

H Pols

1

1 reference

9 February 2018

E Griez

2

1 reference

9 February 2018

K Verburg

3

1 reference

9 February 2018

D van der Werf

4

1 reference

9 February 2018

publication date

1 January 1994

1 reference

9 February 2018

European Archives of Psychiatry and Clinical Neuroscience

published in

1 reference

9 February 2018

volume

244

1 reference

9 February 2018

issue

2

1 reference

9 February 2018

page(s)

81-85

1 reference

9 February 2018

Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02193523

Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02193523

Response to hyperventilation in a group of patients with panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02193523

A neuroanatomical hypothesis for panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02193523

Effects of Clonidine on Anxiety Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02193523

Diagnostic and substance specificity of carbon-dioxide-induced panic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02193523

Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02193523

CO2 challenge of patients with panic disorder.

21 January 2018

1 reference

12 December 2020

Attenuation of carbon dioxide-induced panic after clonazepam treatment

1 reference

12 December 2020

CO2 vulnerability in panic disorder.

1 reference

12 December 2020

Does buspirone have anxiogenic properties?

1 reference

12 December 2020

Specific sensitivity of patients with panic attacks to carbon dioxide inhalation.

1 reference

12 December 2020

Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine.

1 reference

12 December 2020

A cognitive approach to panic.

1 reference

12 December 2020

Response to 35% CO2 as a marker of panic in severe anxiety.

1 reference

12 December 2020

Current concepts. I. Anxiety: the locus coeruleus disconnection

1 reference

12 December 2020

Anxiogenic effect of yohimbine in healthy subjects: comparison with caffeine and antagonism by clonidine and diazepam.

1 reference

12 December 2020

Panic symptoms after inhalation of carbon dioxide.

1 reference

12 December 2020

Anxiogenic properties of yohimbine. I. Behavioral, physiological and biochemical measures.

1 reference

12 December 2020

Hypercapnia and hypoxia: chemoreceptor-mediated control of locus coeruleus neurons and splanchnic, sympathetic nerves

1 reference

12 December 2020

Pharmacologic models of anxiety

1 reference

12 December 2020

Comparison of the panicogenic effect of cholecystokinin 30-33 and carbon dioxide in panic disorder.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02193523

1 reference

9 February 2018

1 reference

9 February 2018